HIGHLIGHTS
- What: ORN is still a recalcitrant skeletal complication of orofacial cancer radiotherapy.
- Who: Yufan Wang and colleagues from the Department of Oral and Maxillofacial Surgery, Peking University Shenzhen Hospital have published the paper: Diagnostic and Therapeutic Approaches to Jaw Osteoradionecrosis, in the Journal: Diagnostics 2024, 2676 of 28/06/2024
- How: Racial disparities also play a part in the incidence of ORN as both earlier and recent Surveillance Epidemiology and End Results (SEER) data showed that the 5-year relative survival rate for Caucasians with head and neck cancers was close to 57 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.